Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-07-22, Stock:NVS, The news for the past five days is as follows:
2020-07-15: NEWS1: Merck Is Now Pursuing Two Coronavirus Vaccines — Is Merck Stock A Buy?.NEWS2: Is Neoleukin Therapeutics a Buy?.
2020-07-16: NEWS1: The Daily Biotech Pulse: Mallinckrodt Gets FDA Panel Backing, Regulatory Setback For Tricida, Relay Therapeutics IPO.NEWS2: Novartis To Sell Covid-19 Drugs At Zero-Profit To Low-Income Countries.NEWS3: Novartis to provide 'no profit' COVID-19 drugs to low income countries.NEWS4: Novartis launches first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19.NEWS5: Stocks - Europe Seen Lower Ahead of ECB Meeting.
2020-07-17: nan
2020-07-20: nan
2020-07-21: NEWS1: Novartis Stock Slips After Sales Miss Views On Coronavirus Impact.NEWS2: What's Behind Novartis' Disappointing Q2 Results.NEWS3: The Dow Is Up Because Europe Is Spending $2.1 Trillion on a Recovery Plan.NEWS4: Biogen to study Spinraza in combination with $2 mln Novartis drug.NEWS5: Novartis' (NVS) Q2 Earnings Surpass Estimates, Sales Miss.NEWS6: Novartis Stock Falls as Swiss Drugmaker Cuts Sales Outlook on Pandemic Woes.NEWS7: Is Amgen Stock A Buy As It Takes A Dual Approach To Targeting Coronavirus?.NEWS8: The Daily Biotech Pulse: Opko Wins CDC Contract, Novartis Lowers Guidance, Pieris Study Placed On Partial Clinical Hold.NEWS9: Cocktails Boost Remy, Pandemic Disrupts Medicines: Earnings Wrap.NEWS10: Novartis CEO Narasimhan on Growth Prospects, Pandemic Disruption.NEWS11: Novartis trims sales outlook after hit from COVID disruptions.NEWS12: Novartis tightens outlook as second-quarter sales, profit fall.NEWS13: Novartis delivered strong H1 performance. FY 2020 guidance confirmed at higher end for core operating income and lower end for sales..

Answer: Rise